Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cells

aDepartment of Internal Medicine II, Gastroenterology, University Hospital Würzburg, Würzburg, Germany

bDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Pecs, Pecs, Hungary

cDepartment of Internal Medicine II, Rheumatology

dDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

eThe Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland, USA

fDepartment of Internal Medicine II, Hepatology, University Hospital Würzburg, Würzburg, Germany

Received 11 October 2022 Accepted 16 January 2023.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.nuclearmedicinecomm.com.

Correspondence to Alexander Weich, MD, Department of Internal Medicine II, Gastroenterology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany, Tel: +49 93120144927; e-mail: [email protected]

留言 (0)

沒有登入
gif